FindTrial
Sign In

Cardiac magnetic resonance evaluation of pregnancy related heart diseases

Cardiac magnetic resonance in the diagnosis and prognosis evaluation of pregnancy related heart diseases

Status
Recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000040057
Enrollment
Unknown
Registered
2020-11-19
Start date
2020-11-16
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pregnancy related heart diseases

Interventions

Gold Standard:cTn, BNP, ECG
Index test:cardiac&#32
magnetic&#32
resonance

Sponsors

West China Second University Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: patients of at least 18 years old, with a clinical diagnosis of peripartum cardiomyopathy, hypertensive heart diseases or gestational diabetes.

Exclusion criteria

Exclusion criteria: contraindication for MRI due to the presence of cardiac pacemaker or defibrillators and other unsafe ferromagnetic objects; claustrophobia; patients with a history of other cardiovascular diseases, hypertension and/or diabetes.

Design outcomes

Primary

MeasureTime frame
cardiac function indexes by cardiac magnetic resonance;indexes to evalute myocardial fibrosis by cardiac magnetic resonance;indexes to evalute myocardial perfusion;—

Countries

China

Contacts

Public ContactHeng Zhang

West China Second University Hospital, Sichuan University

mazy6121981@163.com+86 13882203760

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026